Dr. Princy N. Kumar

Infectious Disease
3800 Reservoir Rd Nw, 
Washington, DC 
Accepting New Patients
Offers Telehealth
3800 Reservoir Rd Nw, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Princy Kumar is an Infectious Disease provider in Washington, Washington, D.c.. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Secondary Adrenal Insufficiency. Her top areas of expertise are HIV/AIDS, COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Myelitis, and Thrombectomy. Dr. Kumar is currently accepting new patients.

Her clinical research consists of co-authoring 112 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in DC
Hospital Affiliations
Medstar Georgetown University Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

MGMC LLC
3800 Reservoir Rd Nw, Washington, DC 20007
Other Locations
MEDSTAR MEDICAL GROUP II LLC
1145 19th St Nw, 311 Mmg At 19th Street Nw, Washington, DC 20036

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 Infected Adults Who Are Virologically Suppressed and Participated in Study LAI116482
Enrollment Status: Completed
Publish Date: June 11, 2024
Intervention Type: Drug
Study Drugs: Long-acting cabotegravir, Long-acting rilpivirine, Rilpivirine, Dolutegravir
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: TJ003234
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1
A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1
Enrollment Status: Completed
Publish Date: March 11, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

112 Total Publications

IL-27 effects on HIVGag-specific CD4 and CD8 T cell function.
IL-27 effects on HIVGag-specific CD4 and CD8 T cell function.
Journal: Frontiers in virology (Lausanne, Switzerland)
Published: December 15, 2025
Similar Doctors
Experienced in Secondary Adrenal Insufficiency
Dr. Wesam H. Moustafa-Hussein
Infectious Disease | Hospital Medicine
Experienced in Secondary Adrenal Insufficiency
Dr. Wesam H. Moustafa-Hussein
Infectious Disease | Hospital Medicine

Alliance Medical Group

8013 Colorado Springs Dr, 
Springfield, VA 
 (14.1 miles away)
571-430-5951
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Wesam Moustafa-Hussein is an Infectious Disease specialist and a Hospital Medicine provider in Springfield, Virginia. Dr. Moustafa-Hussein is rated as an Advanced provider by MediFind in the treatment of Secondary Adrenal Insufficiency. His top areas of expertise are End-Stage Renal Disease (ESRD), Sepsis, Cellulitis, Endoscopy, and Ureteroscopy. Dr. Moustafa-Hussein is currently accepting new patients.

Experienced in Secondary Adrenal Insufficiency
Dr. Maya K. Bryant
Hospital Medicine | Infectious Disease
Experienced in Secondary Adrenal Insufficiency
Dr. Maya K. Bryant
Hospital Medicine | Infectious Disease

Mdics At Bwmc LLC

301 Hospital Dr, 
Glen Burnie, MD 
 (28.9 miles away)
443-949-0814
Languages Spoken:
English
See accepted insurances

Maya Bryant is a Hospital Medicine specialist and an Infectious Disease provider in Glen Burnie, Maryland. Dr. Bryant is rated as an Advanced provider by MediFind in the treatment of Secondary Adrenal Insufficiency. Her top areas of expertise are Sepsis, Hospital-Acquired Pneumonia, Pneumonia, Endoscopy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kumar's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile